Could Patients At Low Cardiovascular Risk Be Better Stratified?
作者信息
Fonseca Francisco Antonio Helfenstein, Izar Maria Cristina
机构信息
Escola Paulista de Medicina da Universidade Federal de São Paulo, São Paulo, SP - Brasil.
Universidade Federal de São Paulo - Medicina, São Paulo, SP - Brasil.
出版信息
Arq Bras Cardiol. 2023 Jun;120(6):e20230310. doi: 10.36660/abc.20230310.
Abstract
摘要
相似文献
1
Could Patients At Low Cardiovascular Risk Be Better Stratified?心血管风险较低的患者能否得到更好的分层？
Arq Bras Cardiol. 2023 Jun;120(6):e20230310. doi: 10.36660/abc.20230310.
2
Cardiovascular Risk Assessment and Prevention Across the Life Course: Propensity, Determinants, Risk, Disease.全生命周期心血管风险评估与预防：倾向、决定因素、风险、疾病
J Am Coll Cardiol. 2023 Feb 21;81(7):633-635. doi: 10.1016/j.jacc.2022.12.007.
3
Focus on population studies in cardiovascular risk assessment.关注心血管风险评估中的人群研究。
Eur J Prev Cardiol. 2024 Jan 5;31(1):1-2. doi: 10.1093/eurjpc/zwad371.
4
Redefining Cardiovascular Risk Assessment as a Spectrum: From Binary to Continuous.将心血管风险评估重新定义为一个范围：从二元到连续。
J Am Coll Cardiol. 2024 Feb 6;83(5):574-576. doi: 10.1016/j.jacc.2023.11.026.
5
Adult Cardiovascular Health Risk and Cardiovascular Phenotypes of Prematurity.成人心血管健康风险与早产的心血管表型
J Pediatr. 2020 Dec;227:17-30. doi: 10.1016/j.jpeds.2020.09.019. Epub 2020 Sep 12.
6
Increased cardiovascular risk in boys born with hypospadias: intriguing observations and remaining questions.
Eur Heart J. 2022 May 14;43(19):1846-1848. doi: 10.1093/eurheartj/ehac152.
7
Editor comment: Focus on cardiovascular risk assessment.编辑评论：关注心血管风险评估。
Eur J Prev Cardiol. 2022 Mar 30;29(4):577-579. doi: 10.1093/eurjpc/zwac051.
8
Transgender People May Face Elevated, Often Untreated Heart Risks.跨性别者可能面临更高且往往未得到治疗的心脏风险。
Circulation. 2021 Jul 20;144(3):243-245. doi: 10.1161/CIRCULATIONAHA.121.055711. Epub 2021 Jul 19.
9
Risk factors for cardiovascular disease: the known unknown.心血管疾病的风险因素：已知的未知因素。
Eur J Prev Cardiol. 2024 Oct 10;31(14):e106-e107. doi: 10.1093/eurjpc/zwad392.
10
Spotlight on Cardiovascular Risk Assessment in Patients with Inflammatory Bowel Disease.炎症性肠病患者心血管风险评估聚焦
Dig Dis Sci. 2022 Sep;67(9):4326-4329. doi: 10.1007/s10620-022-07449-0. Epub 2022 Mar 18.
本文引用的文献
1
Determining Percentiles of Atherosclerotic Cardiovascular Risk According to Sex and Age in a Healthy Brazilian Population.根据性别和年龄确定巴西健康人群的动脉粥样硬化性心血管疾病风险的百分位数。
Arq Bras Cardiol. 2023 Jun;120(6):e20220552. doi: 10.36660/abc.20220552.
2
Pharmacoinvasive Strategy in Elderly Up to 75 Years or Non-Elderly: Analysis of Biochemical and Cardiac Magnetic Resonance Imaging Parameters.老年（75 岁及以下）和非老年人群的药物侵入性策略：生化和心脏磁共振成像参数分析。
Arq Bras Cardiol. 2023 Jan 9;120(1):e20220177. doi: 10.36660/abc.20220177. eCollection 2023.
3
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis.固定剂量联合治疗与不联合阿司匹林用于心血管疾病一级预防的疗效：一项个体参与者数据荟萃分析。
Lancet. 2021 Sep 25;398(10306):1133-1146. doi: 10.1016/S0140-6736(21)01827-4. Epub 2021 Aug 29.
4
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018年美国心脏协会/美国心脏病学会/美国心血管和肺康复协会/美国医师助理学会/美国心脏协会临床心脏病学分会/美国预防医学学会/美国糖尿病协会/美国老年医学会/美国药剂师协会/美国医学主任协会/美国国家脂质协会/美国初级保健医师学会血液胆固醇管理指南：美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2019 Jun 25;73(24):e285-e350. doi: 10.1016/j.jacc.2018.11.003. Epub 2018 Nov 10.
5
Improving patient risk communication: Translating cardiovascular risk into standardized risk percentiles.改善患者风险沟通：将心血管风险转化为标准化的风险百分位数。
Am Heart J. 2018 Apr;198:18-24. doi: 10.1016/j.ahj.2017.12.005. Epub 2017 Dec 7.
6
[Not Available].[无可用内容]。
Arq Bras Cardiol. 2017 Jul;109(2 Supl 1):1-76. doi: 10.5935/abc.20170121.
7
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.低密度脂蛋白导致动脉粥样硬化性心血管疾病。1. 来自遗传、流行病学和临床研究的证据。欧洲动脉粥样硬化学会共识小组的共识声明。
Eur Heart J. 2017 Aug 21;38(32):2459-2472. doi: 10.1093/eurheartj/ehx144.
8
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.男性和女性的 LDL 降低治疗的疗效和安全性：27 项随机试验中 174000 名参与者的个体数据汇总分析。
Lancet. 2015 Apr 11;385(9976):1397-405. doi: 10.1016/S0140-6736(14)61368-4. Epub 2015 Jan 9.
Zotero 插件